Douglas Swirsky - Jun 28, 2023 Form 4 Insider Report for Cellectar Biosciences, Inc. (CLRB)

Role
Director
Signature
/s/ Christina Blakley, attorney-in-fact for Douglas Swirsky
Stock symbol
CLRB
Transactions as of
Jun 28, 2023
Transactions value $
$0
Form type
4
Date filed
6/28/2023, 06:27 PM
Previous filing
Mar 28, 2023
Next filing
Mar 19, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLRB Stock option (right to buy) Award $0 +37.5K +108.93% $0.00 71.9K Jun 28, 2023 Common Stock 37.5K $1.85 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option shall vest in full on June 28, 2024, subject to the reporting person's continued service through the applicable vesting date.